Siemens Demonstrates Workflow Efficiency in Echocardiography at ACC 2009
Instantaneous full-volume imaging and knowledge-based workflow applications streamline exam processes
ORLANDO, Fla., March 28 /PRNewswire-FirstCall/ -- During the 58th Annual Scientific Session of the American College of Cardiology (ACC) from March 29-31 in Orlando, Fla., Siemens Healthcare ...
Siemens Highlights Cardiology Excellence from Prevention to Follow-up at ACC 2009
Siemens portfolio of cardiology applications covers the entire spectrum - from medical imaging, laboratory diagnostics, IT and customized support offerings
ORLANDO, Fla., March 27 /PRNewswire/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) demonstrates its commitment to excelle...
Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009
SOMATOM Definition Flash sets the bar higher for cardiology
ORLANDO, Fla., March 26 /PRNewswire-FirstCall/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) demonstrates the fastest speed and lowest dose for cardiac applications with the SOMATOM (R) Definition Flash dual source com...
Boston Scientific Announces Schedule For ACC 2009
NATICK, Mass., March 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the schedule of the Company's major events and news announcements at the 58th Annual Scientific Session of the American College of Cardiology / i2 Summit, which runs from March 28-31 in O...
Siemens Highlights Its Ultimate Hybrid System at ACC 2009
Artis zee family brings a broad range of imaging solutions to cardiology
ORLANDO, Fla., March 25 /PRNewswire-FirstCall/ -- Siemens Healthcare ( www.usa.siemens.com/healthcare ) provides imaging excellence and workflow enhancements for cardiology with its ultimate hybrid at the 58th Annual ...
Siemens Highlights Cardiac-Specific C-Reactive Protein (hsCRP) Test at ACC 2009
hsCRP test used in JUPITER trial extended across portfolio
ORLANDO, Fla., March 24 /PRNewswire/ -- According to a guidance document issued by the FDA(1), not all high sensitivity CRP (c-reactive protein) tests are cleared to identify and assess individuals at risk for future cardiovascular...
Siemens Demonstrates New Version of Multimodality Cardiology Image Management Solution at ACC 2008
Siemens Showcases Integrated Approach to Cardiovascular Image and Information Management
CHICAGO, March 31 /PRNewswire-FirstCall/ -- Siemens Healthcare
(http://www.siemens.com/healthcare ) will demonstrate the enhanced capabilities of
the latest version of its syngo...
Experts from Penn's School of Medicine to present at ACC Annual Scientific Session
Penn experts will present research findings that could come to define new standards of cardiovascular diagnostics and care at this weekends conference of the American College of Cardiology, the foremost professional society representing heart specialists throughout the world. These experts will ga...
SCAI and ACC announce new interventional cardiology meeting
(September 10, 2007 -- WASHINGTON, DC) The Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) announced today that they will hold a unified interventional cardiology meeting in Chicago, March 29April 1, 2008. The meeting will be known as T...
See More, Do More: Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC
New Artis zee Family Provides Interventional Cardiologists with Enhanced Imaging for Faster, More Precise Procedures
CHICAGO, March 31 /PRNewswire-FirstCall/ -- According to the American
Heart Association, cardiovascular disease ranks as America's No. 1 killer,
with an average of ...
Acc in Medical Technology
RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009
FRANKLIN, Mass., March 27 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the first data from its pilot safety trial for RenalGuard(R) will be presented in a poster ...
Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
SAN MATEO¿ Calif.¿ March 23 /PRNewswire/ -- Results from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at 10:30 a.m. EDT on Sunday, March 29, at the American College of Cardiology's (ACC...
Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
Results of Mouse Model of Diabetes with Haptoglobin 2-2 Genotype Show
Modification of HDL Structure and Defective Reverse Cholesterol Transport
MONTVALE, N.J., March 31 /PRNewswire-FirstCall/ -- Synvista
Therapeutics, Inc. (Amex: SYI ) announces data from a study of diabetic mice
with the H...
Media Advisory: ACC Updated Schedule
Schering-Plough Announces Presentation Of Phase II Trial Results
For Novel Oral Thrombin Receptor Antagonist At The 2007 Annual
Meeting Of The American College Of Cardiology/i2 Summit
KENILWORTH, N.J., March 16, 2007 /PRNewswire-FirstCall/ --
Schering-Plough Corporation announced today that result...
Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2
Predicts Heart Disease Risk in Metabolic Syndrome Patients
NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Study results show
that elevated lipoprotein-associated phospholipase A2 (Lp-PLA2), a
cardiovascular-specific inflammatory enzyme associated with
unstable plaque that can lead to heart attack and stroke, is
especially predictive of heart disease risk in ...
Study Presented at ACC Shows Treatment With ISIS 301012 Added to
Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C
Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C
Levels of Less Than 70 mg/dL
* ISIS 301012 coadministered with statins for only five weeks at
400 mg/week lowered LDL-C 47% beyond the levels achieved with
statins alone, with similarly favorable effects on other
NEW ORLEANS and CARLSBAD, Calif., March 26, 2007
/PRNewswire-FirstCall/ -- Isis Pharmaceuticals...
Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical
Data for INO-1001 at ACC Demonstrating PARP Inhibition and
Anti-inflammatory Activity in Plasma of Patients Undergoing Primary
Percutaneous Coronary Intervention
BEVERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek
Pharmaceuticals Corporation announced today the presentation of
positive Phase 2 clinical data demonstrating the safety of INO-1001
as well as the potential for INO-1001 as a preventative agent for
cardiac reperfusion injury. The study was cond...
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012
in Familial Hypercholesterolemia Patients Presented at ACC
* Homozygous FH patients already being treated with maximally
tolerated lipid-lowering therapies experienced 50% further
reductions in LDL-C with similar reductions in other atherogenic
when treated with 300 mg/week ISIS 301012
NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007
New Bisphenol A Study Is of Very Limited Relevance to Human Health
...g companies engaged in the business of chemistry. acc
members apply the science of chemistry to make inn... make people's lives better, healthier and safer. acc
is committed to improved environmental, health and... and security have always been primary concerns of acc
members, and they have intensified their efforts, ...
Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure
...sented at Late-Breaking Clinical Trials Session at acc
58th Annual Scientific Session; Results Published ...y results presented in this important forum at the acc
and published in the prestigious journal The Lance... 858.717.2310 (mobile number while at acc
Acc in Biological News
LDL particle measurement by NMR recognized by ADA, ACC
Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number by nuclear magnetic resonance (NMR) is one of the more accurate ways to evaluate cardiometabolic ...
Sustainable agriculture at the ESA Annual Meeting
...y, and Biofuels I. Tuesday, Aug. 4, 3:40 p.m., Taos room, ACC
Shashi Kumar: PS 42 - Agricultural Landscapes. Wed., Aug. 5, 5-6:30 p.m., Exhibit Hall, acc
Millisecond brain signals predict response to fast-acting antidepressant
...CC), signals a better response.
To find out if acc
activity might also forecast response to glutamate...n to activate the ACC. While healthy participants' acc
activity dropped off as they quickly habituated to the faces, patients' acc
activity showed an opposite trend. The more robust...
Cardiologists and heart surgeons meet for 'Controversies and Advances' conference
...thoracic Surgery at Cedars-Sinai; and John G. Harold, M.D., FACC, cardiologist and President, California Chapter American College of Cardiology (ACC), acc
Governor for Southern California, and a recent Chief of Staff at Cedars-Sinai.
Sessions on Thursday, Oct. 4, will address coronary artery disease (...
Smoking changes brain chemistry
...ne pack year), the lower the NAA level.
is involved in mediating conditioned reinforcement...ol dependence.
Choline concentrations in the acc
were slightly lower in the smokers compared with t.... Gür said. "The degree of reduction of NAA in the acc
depends on the amount of tobacco consumed over tim...
Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet
...rts to burn fat while simultaneously shutting down acc
through a chemical modification called phosphoryla...B3 serves as a go-between for an enzyme that marks acc
for degradation," says Jose Heredia, a graduate st...pose tissue usually rise only during fasting, when acc
should be turned off. Heredia and co-first author ...
Acc in Biological Technology
Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session
- First Stem Cell Trial to Show Dose-related Significant Improvement in Perfusion -
ORLANDO, Fla., March 30 /PRNewswire/ -- Amorcyte, Inc. (Amorcyte) today announced data from its Phase I clinical trial of AMR-001, the company's lead product for the treatment of damaged heart muscle fol...
Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
LDL, Non-HDL and apoB measurement helps physicians guide therapy for cardiometabolic risk patients
BIRMINGHAM, Ala., April 22 /PRNewswire/ -- The determination of LDL,
non-HDL and apoB are now recognized as valid, accurate and recommended
methods of guiding and achieving ...
Boston Scientific Announces Schedule for ACC 2008
NATICK, Mass., March 25 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) today announced the schedule of the Company's major
events and news announcements at the Society for Cardiovascular Angiography
and Interventions SCAI Annual Scientific Sessions in Partnership with th...
Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
DENVER, March 20 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation
(OTC Bulletin Board: CONX), a worldwide developer and marketer of
diagnostic test kits, has announced it will be exhibiting its
AspirinWorks(R) Test at the American College of Cardiology (ACC) 57th
Annual Scientific Sessio...
Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
VAP expanded cholesterol test can help clinicians identify best treatment options for patients at risk of heart disease
BIRMINGHAM, Ala., March 7 /PRNewswire/ -- Atherotech, Inc., a
cardio-diagnostic company, today announced it will be exhibiting its VAP
Cholesterol Test(R) in Booth...
Resverlogix Provides Quarterly Update
...recent Wall Street Journal article," stated McCaffrey.
At the most recent acc
conference held in Orlando Florida RVX-208 was the subject of two key plena...s and cardiovascular disease.
In a second keynote address during the same acc
conference Dr. Prediman K. Shah, Director of the Division of Cardiology and...
New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando
...y 1) inaccurate individualized assessment of cardiovascular risk and 2) inadequate monitoring of vascular response to treatments.
Note: During the acc
2009, Endothelix will hold a "Drink & Draw" event at Rosen Plaza Hotel Backstage Club where a lucky person will win the VENDYS round-tri...
Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship
...d capability and adaptability Sage Intergy
will be able to:
-- Capture the data nece...ollowed by calls from debt
collectors. This allows acc
to work in a cooperative manner with patients to
i...l its clinical trials into the EHR alert
will be able to identify candidates for clinical t...
Anthera Presents Data on Varespladib at ATVB Meeting
...im Trias, Ph.D., Senior
Vice President of Preclinical Development at Anthera Pharmaceuticals, Inc.
"Along with the Phase II PLASMA data presented at acc
year, today's announcement gives us added confidence as we move the
Varespladib clinical program forward," said Dr. James E. Pennington, ...
Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
...in Chicago on
Monday 31 March at 10.00 CDT / 16.00 BST. Details of how to dial in and/or
watch live streaming of the briefing can be obtained from the acc
For further information please contact:
Laura Gallagher Senior Press Officer Imperial College London e-mail: L.Gallagher@imperi...
Acc in Biological Definition
... is found together with unsaturated amino acids in lantibiotics (antibiotic peptides of microbial origin). 1-Aminocyclopropane-1-carboxylic acid ( acc
) is a small disubstituted cyclic amino acid and a key intermediate in the production of the plant hormone ethylene .
In addition to amino acids ...